Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
Mulder, N. H. ; Sleijfer, D. Th. ; Vries, E. G. E. ; Koops, H. Schraffordt ; Willemse, P. H. B.
Springer
Published 1990
Springer
Published 1990
ISSN: |
1432-1335
|
---|---|
Keywords: |
Malignant melanoma ; Chemotherapy
|
Source: |
Springer Online Journal Archives 1860-2000
|
Topics: |
Medicine
|
Notes: |
Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
|
Type of Medium: |
Electronic Resource
|
URL: |
_version_ | 1798295652286857216 |
---|---|
autor | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
autorsonst | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
book_url | http://dx.doi.org/10.1007/BF01612907 |
datenlieferant | nat_lic_papers |
hauptsatz | hsatz_simple |
identnr | NLM205268714 |
issn | 1432-1335 |
journal_name | Journal of cancer research and clinical oncology |
materialart | 1 |
notes | Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. |
package_name | Springer |
publikationsjahr_anzeige | 1990 |
publikationsjahr_facette | 1990 |
publikationsjahr_intervall | 8009:1990-1994 |
publikationsjahr_sort | 1990 |
publisher | Springer |
reference | 116 (1990), S. 301-302 |
schlagwort | Malignant melanoma Chemotherapy |
search_space | articles |
shingle_author_1 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
shingle_author_2 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
shingle_author_3 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
shingle_author_4 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. |
shingle_catch_all_1 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma Malignant melanoma Chemotherapy Malignant melanoma Chemotherapy Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. 1432-1335 14321335 Springer |
shingle_catch_all_2 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma Malignant melanoma Chemotherapy Malignant melanoma Chemotherapy Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. 1432-1335 14321335 Springer |
shingle_catch_all_3 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma Malignant melanoma Chemotherapy Malignant melanoma Chemotherapy Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. 1432-1335 14321335 Springer |
shingle_catch_all_4 | Mulder, N. H. Sleijfer, D. Th. Vries, E. G. E. Koops, H. Schraffordt Willemse, P. H. B. Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma Malignant melanoma Chemotherapy Malignant melanoma Chemotherapy Summary Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. 1432-1335 14321335 Springer |
shingle_title_1 | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
shingle_title_2 | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
shingle_title_3 | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
shingle_title_4 | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
source_archive | Springer Online Journal Archives 1860-2000 |
timestamp | 2024-05-06T09:39:36.518Z |
titel | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
titel_suche | Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma |
topic | WW-YZ |
uid | nat_lic_papers_NLM205268714 |